As we close out this year's PTSD Awareness Month, we wanted to take a quick look at some of the many resources that the CDP and other organizations have compiled to help further the effort.
It’s tough to keep up with the “latest and greatest” interventions for Post-Traumatic Stress Disorder (PTSD). It seems like there’s constantly a new “breakthrough” that never fully delivers. As a scientist-practitioner, I don’t pay much attention until I see a strong research base. So until recently, I’ve all but ignored claims that psychedelic drugs (MDMA, psilocybin, etc.) could bolster recovery from PTSD. However, it’s tough to ignore the successes reported in a recent Phase 3 trial.
Based on clinical experience, training and supervision, and findings from the literature, Dr. Rogers explores various issues related to the diagnosis of and diagnosing PTSD in this blog. During this month devoted to awareness of PTSD, it is appropriate to take time focus on the diagnosis and the practice of diagnosing PTSD.
The number of U.S. military veterans who reported social anxiety disorder during their lifetimes, according to a recent study published online ahead of print in the Journal of Affective Disorders -- The hidden burden of social anxiety disorder in U.S. military veterans: Results from the National Health and Resilience in Veterans Study.
June is Post-Traumatic Stress Disorder Awareness Month. Though we have come a long way in informing the public about PTSD, there is still plenty of work to do in this effort. The Center for Deployment Psychology provides information and training on the topic all year, but in June we make a special effort to highlight PTSD, resources, and evidence-based treatments.